# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN-TD
- Date: 1921-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cormac Ellingsworth-Daly, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- He is afraid a heart diagnosis will stop the expedition he has promised to lead **S**
- He will be weeks from a hospital at sea and in the far south **S**

## Your goals

- No cigarettes from the quit date, confirmed at each visit. Target: 1921-09-08. Recorded outcome: Not smoked since the quit date a week after intake; varenicline continued to 24 weeks. **S**
- LDL cholesterol below 55 mg/dL with at least a 50% reduction by four months. Target: 1921-09-08. Recorded outcome: 44 mg/dL, from 168. **S**
- Blood pressure below 130/80 mmHg by six weeks. Target: 1921-06-23. Recorded outcome: 128/80 at six weeks. **S**
- Free of angina in daily activity, and a symptom-limited exercise test of at least 10 METs without ischemia before departure. Target: 1921-09-08. Recorded outcome: No angina since the stent; about 12.8 METs without angina or ST changes. **S**
- Drinking within the low-risk limit, with an AUDIT-C below 4, by four months. Target: 1921-09-08. Recorded outcome: AUDIT-C 3, from an AUDIT of 12; two drinks at most on four evenings a week. **S**
- At least 15 sessions of cardiac rehabilitation before departure. Target: 1921-09-08. Recorded outcome: 18 sessions completed. **S**

## What we agreed to do

- Cardiology consultation in two weeks with coronary CT angiography for suspected stable angina, and advice on revascularization and on fitness for the expedition. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dose. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitline. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-up. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Prediabetes: diet and activity counseling and HbA1c in about four months. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Prediabetes and Type 2 Diabetes: Screening (2021) **S**
- Raise metoprolol succinate to 100 mg for persisting angina, with an echocardiogram, and revascularization of the proximal LAD lesion if angina persists despite medical therapy or he prefers it after a shared decision. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Expedition plan: a symptom-limited exercise test before departure, a written cardiac summary with ECG and stent card, three months' extra medicines split between two bags, an automated external defibrillator and emergency cardiac medicines on board, a satellite link for telemedicine, an evacuation plan to the nearest cardiac centers along the route, and advice on cold stress. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Invasive coronary angiography with a drug-eluting stent to the proximal LAD, then aspirin with clopidogrel for six months and aspirin alone after. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Cardiac rehabilitation after the stent, three sessions a week until departure, with a home exercise plan for the voyage. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Add ezetimibe 10 mg because LDL cholesterol was 62 mg/dL on atorvastatin 80 mg, above the target below 55. Guideline: 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**

## Follow-up

- 1921-05-12: New patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral **S**
- 1921-05-26: Two-week follow-up and cardiology consultation with coronary CT angiography and echocardiogram **S**
- 1921-06-23: Six-week review: angina on medical therapy, smoking, and a shared decision about coronary angiography and stenting **S**
- 1921-07-21: Ten-week review: three weeks after the stent, lipids, cardiac rehabilitation, smoking and alcohol **S**
- 1921-08-11: Periodic adult preventive visit **S**
- 1921-09-08: Four-month review before departure: exercise test, lipids, HbA1c, and the expedition medical plan **S**

This teaching document does not replace care from a qualified clinician.
